Healthcare
M&A Advisory
Technology
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Repros Therapeutics. United States. Announced Date 19/06/2013. Closed Date 25/06/2013. Deal value: $71m. Common stock. Industry: Repros Therapeutics is a biopharmaceutical company focused on the development of therapies for reproductive health.